Stocks

Nuclear Bomb

Posted by : nikhil_khetan

i think it is best time to accumulate Bharti, it is available on sale. just check institutional buyings below 280...

BSE Announcements on Teledata Info

Posted by : bababull

end of teledata. Sob! Finito! Thats the end! Climax! Swindler himself swindled :( . Where are the bulls, ramge, sbalu, moron, etc. All exited conveniently earlier.

A RIL spokesperson says the firm has not violated any regulations

Posted by : bhusbhac

Strange this October matter was also propogated on Livemint? Has anything fresh happened or about to happen and some persons have got hold of some advance information?

To me it sounds far fetched since this sale has been duly recorded in books of RIL. Cannot understand promoters risking all of RIL for such a small amount which resulted in a small profit of a few hundred crores out of a transaction of Rs 4000 crores.

Could be mistake or miinterpretation somewhere. Well well one more dispute in hand to play with this stock. I think that since this matter was raised in Parliament it would more likely be a cleaning exercise.

i think its going to go up

Posted by : Guest

alloted 12,00,000 equity shares of Rs 10/- each to Citigroup on preferential basis at a price of Rs 1,280/- per share. The confidence of issuing shares deserves some time to regain its price

Waiting for a good news

Posted by : jpe

What would be the good news which is going to take telcom up?

aftek

Posted by : fds

This report was published on 9th sept09 by CARE.Pl read and give your comments

CARE ASSIGNS ‘A’ RATING TO THE NCD ISSUE OF
AFTEK LTD.
CARE has assigned a ‘CARE A’ (Single A) rating to Aftek’s proposed Non Convertible
Debentures (NCD) aggregating Rs.50 crore.
Instruments with this rating are considered to offer adequate safety for timely servicing of debt obligations. Such instruments carry low credit risk.
CARE assigns `+` or `-` signs to be shown after the assigned rating (wherever
necessary) to indicate the relative position within the band covered by the rating
Rating Rationale
The rating is based on Aftek’s more than twenty year track record, comfortable
liquidity position, low debt levels and high interest coverage ratio, high profit margins,strength of Aftek’s technical team, diversification efforts undertaken and the company’s capacity to generate cash.The rating, however, is constrained by the dependence on uncertain export market,technology & product life-cycle risk and negative outlook of the industry in the shortto-medium term.
The ability of the company to launch its new products successfully and to effectively integrate its acquisitions remains the key rating sensitivities
Company Profile
Aftek was established in 1986 when it started with selling assembled computers and peripherals. Post 1995, after gaining substantial exposure in the IT industry, Aftek started offering software services which form more than 90% of its offerings. Aftek is mainly engaged in providing services in Information Technology, embedded systems,hardware engineering, testing services and solutions.
Aftek was traditionally engaged in the capacity of an intermediary between the
customer and the testing-services provider. The company has planned to introduce product/offerings of its own to the customers, which will help Aftek diversify its business and improve margins. Moreover, the new offerings are primarily aimed at domestic market which would not carry the foreign exchange risk posed by a highly export dependent revenue structure in the past.Aftek had reported a total income of Rs.392.54 crore and earned a PAT of Rs.80.94crore in FY08.
The gearing ratios of the company were comfortable as at end of FY07, FY08 and FY09 (provisional). Interest coverage has been fairly adequate due to strong operation margin and low gearing levels.
In FY09, (as per provisional results) Aftek reported a loss of Rs.6.95 crore due to diminution in value of investments of its subsidiary Arexera AG, which was notional in nature. Notwithstanding the above, Aftek’s liquidity position was comfortable as it had high level of cash balances.Analyst Contact
Name: Umeshpratap Singh
Email: umesh.singh@careratings dot com

A RIL spokesperson says the firm has not violated any regulations

Posted by : bhusbhac

Source Livemint dated 23rd November, 2009

Sebi issues notice to RIL on RPL share sale

A RIL spokesperson says the firm has not violated any regulations

PTI
Email Print
del.icio.us
digg
newsVine
font size Mumbai: Market regulator Sebi is understood to have asked RIL as to why it should not be barred from accessing the market in relation to violation of insider trading norms - a charge denied by the company.

Reliance Industries has not violated any regulations, a spokesperson for Mukesh Ambani-led firm said on Monday, when asked about Sebi’s show-cause notice in relation to sale of shares of its then subsidiary Reliance Petroleum in late 2007.

Securities and Exchange Board of India (Sebi) is understood to have issued a show-cause notice in April this year against Reliance Industries, stating why it should not take action for possible violation of insider trading norms in relation to sale of shares of then subsidiary RPL in November 2007.

Subsequent to this, Sebi in early October is said to have amended the notice, asking RIL to explain why it should not be barred from accessing the market, directly or indirectly, and why a direction should not be issued for disgorgement of proceeds from the said sale of RPL shares.

“Reliance Industries Ltd has always abided by all rules and regulations of Sebi and hence, has neither violated any provisions of Insider Trading nor has acted in any manner so as to attract provisions under the related sections of SEBI Act,” the spokesperson said in an emailed statement.

“We have accordingly, submitted our detailed reply to Sebi and have not received any further communication in this regard,” the spokesperson added.

The notice is said to have been issued following a probe into charges of insider trading in securities of group firm Reliance Petroleum (RPL). Sebi is believed to have begun the probe in early 2008, after the issue was raised in Parliament.

RIL had sold over 4% equity in RPL in November 2007, prior to which heavy selling, allegedly by various group entities, was noticed in the futures contract of RPL.

RPL, which last traded as a separate entity on the bourses on 24 September, has since been merged with RIL.

buyer of arch pharmalab

Posted by : smart hits

i am buyer of arch pharma if anybody intersted to sell then pls cont on 9819833160 or parshwanathcapital@gmail

HOLD

Posted by : eagle's eye

I think one should start booking profits at around Rs. 140 as nifty correction is due this week.

Waiting for a good news

Posted by : jpe

What would be the good news which is going to take telcom up?